Report cover image

Mesotherapy Market Size, Share, Trends, Industry Analysis Report: By Type (Solutions, Masks, Creams, Devices, and Others), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2

Publisher Polaris Market Research & Consulting LLP
Published May 01, 2025
Length 114 Pages
SKU # PLRS20199101

Description

The global mesotherapy market size is expected to reach USD 1,543.31 million by 2034, according to a new study by Polaris Market Research. The report “Mesotherapy Market Size, Share, Trends, Industry Analysis Report: By Type (Solutions, Masks, Creams, Devices, and Others), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Mesotherapy is a minimally invasive procedure that involves microinjections of vitamins, enzymes, hormones, and other active ingredients into the skin to address aesthetic and medical concerns. It is commonly used for skin rejuvenation, fat reduction, hair loss treatment, and pain management. The technique allows for targeted delivery of active compounds, enhancing their effectiveness while minimizing systemic side effects. Originating in France, mesotherapy has gained widespread adoption in dermatology and aesthetic medicine due to its ability to offer non-surgical solutions with minimal downtime.

The mesotherapy market growth is driven by increasing demand for non-invasive cosmetic treatments, rising awareness of aesthetic procedures, and advancements in skincare formulations. The growing aging population, coupled with the rising prevalence of hair loss and skin-related conditions, has further contributed to market expansion. Mesotherapy market opportunities include technological advancements in injection techniques and the development of new bioactive formulations. Emerging trends, such as the integration of nanotechnology and personalized mesotherapy solutions, are shaping the market landscape. Additionally, the increasing popularity of medical tourism and expanding access to aesthetic treatments in developing regions are creating growth opportunities.

Mesotherapy Market Report Highlights:

By type, the solutions segment holds the largest share of the mesotherapy market revenue due to their versatility in treating various skin and hair concerns.

By application, the anti-ageing segment dominates the mesotherapy market share as consumers seek non-surgical solutions for skin rejuvenation.

By region, North America is leading in terms of market share. This dominance is primarily attributed to the region's well-established cosmetic industry, widespread acceptance of non-invasive aesthetic treatments, and higher disposable income among consumers.

In Europe, the mesotherapy market is experiencing significant growth, driven by the increasing demand for minimally invasive aesthetic procedures.

The market features several active companies contributing to its growth and innovation. A few key players include Dermaqual; Dermoaroma; Fusion Meso; Institute BCN; Koru Pharma Co., Ltd.; Mesoskinline; Mesotech S.r.l.; OstarBeauty; Persebelle; and Toskani Cosmetics. These companies specialize in developing and manufacturing mesotherapy products and devices, offering a range of solutions for skin rejuvenation, fat reduction, hair restoration, and other aesthetic treatments.

Polaris Market Research has segmented the mesotherapy market report based on type, application, end use, and region:

By Type Outlook (Revenue – USD Million, 2020–2034)

Solutions

Masks

Creams

Devices

Others

By Application Outlook (Revenue – USD Million, 2020–2034)

Anti-Ageing

Facial Rejuvenation

Acne & Scar Treatment

Stretch Marks

Fat Loss

Hair Loss

Others

By End Use Outlook (Revenue – USD Million, 2020–2034)

Hospitals

Dermatology & Cosmetic Clinics

Others

By Regional Outlook (Revenue – USD Million, 2020–2034)

North America
  • US
  • Canada
Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

114 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. MENA Gaucher Disease Treatment Market Insights
4.1. Gaucher Disease Treatment Market – Market Snapshot
4.2. Gaucher Disease Treatment Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Expansion of Centralized Healthcare System
4.2.1.2. Growing Public-Private Partnership
4.2.2. Restraints and Challenges
4.2.2.1. High Initial Cost of Manufacturing
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Gaucher Disease Treatment Market Trends
4.6. Value Chain Analysis
5. MENA Gaucher Disease Treatment Market, by Type
5.1. Key Findings
5.2. Introduction
5.2.1. MENA Gaucher Disease Treatment Market, by Type, 2020-2034 (USD million)
5.3. Type 1
5.3.1. MENA Gaucher Disease Treatment Market, by Type 1, by Region, 2020-2034 (USD million)
5.4. Type 3
5.4.1. MENA Gaucher Disease Treatment Market, by Type 3, by Region, 2020-2034 (USD million)
5.5. Type 2
5.5.1. MENA Gaucher Disease Treatment Market, by Type 2, by Region, 2020-2034 (USD million)
6. MENA Gaucher Disease Treatment Market, by Therapy
6.1. Key Findings
6.2. Introduction
6.2.1. MENA Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD million)
6.3. Enzyme Replacement Therapy (ERT)
6.3.1. MENA Gaucher Disease Treatment Market, by Enzyme Replacement Therapy (ERT), by Region, 2020-2034 (USD million)
6.4. Substrate Reduction Therapy (SRT)
6.4.1. MENA Gaucher Disease Treatment Market, by Substrate Reduction Therapy (SRT), by Region, 2020-2034 (USD million)
6.5. Others
6.5.1. MENA Gaucher Disease Treatment Market, by Others, by Region, 2020-2034 (USD million)
7. MENA Gaucher Disease Treatment Market, by Distribution Channel
7.1. Key Findings
7.2. Introduction
7.2.1. MENA Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD million)
7.3. Hospital Pharmacies
7.3.1. MENA Gaucher Disease Treatment Market, by Hospital Pharmacies, by Region, 2020-2034 (USD million)
7.4. Retail Pharmacies
7.4.1. MENA Gaucher Disease Treatment Market, by Retail Pharmacies, by Region, 2020-2034 (USD million)
7.5. Online Pharmacies
7.5.1. MENA Gaucher Disease Treatment Market, by Online Pharmacies, by Region, 2020-2034 (USD million)
8. MENA Gaucher Disease Treatment Market, by Geography
8.1. Key Findings
8.2. Introduction
8.2.1. Gaucher Disease Treatment Market Assessment, By Geography, 2020-2034 (USD million)
8.3. Gaucher Disease Treatment Market – Algeria
8.3.1. Algeria: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD million)
8.3.2. Algeria: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD million)
8.3.3. Algeria: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD million)
8.3.4. Gaucher Disease Treatment Market – IRAQ
8.3.4.1. IRAQ: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD million)
8.3.4.2. IRAQ: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD million)
8.3.4.3. IRAQ: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD million)
8.3.5. Gaucher Disease Treatment Market – Iran
8.3.5.1. Iran: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD million)
8.3.5.2. Iran: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD million)
8.3.5.3. Iran: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD million)
8.4. Gaucher Disease Treatment Market – Saudi Arabia
8.4.1. Saudi Arabia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD million)
8.4.2. Saudi Arabia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD million)
8.4.3. Saudi Arabia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD million)
8.4.4. Gaucher Disease Treatment Market – MOROCCO
8.4.4.1. MOROCCO: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD million)
8.4.4.2. MOROCCO: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD million)
8.4.4.3. MOROCCO: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD million)
8.4.5. Gaucher Disease Treatment Market – Libya
8.4.5.1. Libya: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD million)
8.4.5.2. Libya: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD million)
8.4.5.3. Libya: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD million)
8.4.6. Gaucher Disease Treatment Market – Egypt
8.4.6.1. Egypt: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD million)
8.4.6.2. Egypt: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD million)
8.4.6.3. Egypt: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD million)
8.4.7. Gaucher Disease Treatment Market – Turkey
8.4.7.1. Turkey: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD million)
8.4.7.2. Turkey: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD million)
8.4.7.3. Turkey: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD million)
8.4.8. Gaucher Disease Treatment Market – Rest of MENA
8.4.8.1. Rest of MENA: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD million)
8.4.8.2. Rest of MENA: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD million)
8.4.8.3. Rest of MENA: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD million)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Amicus Therapeutics, Inc.
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. CANbridge Life Sciences Ltd.
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Eli Lilly and Company
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Johnson & Johnson, Inc.
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Lingyi Biotechnology
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Protalix Biotherapeutics Inc.
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Sanofi
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Spur Therapeutics
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Takeda Pharmaceutical
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us